Gangrene Treatment Market Market Size

Gangrene Treatment Market size was USD 2.1 billion in 2025 and is anticipated to reach USD 3.8 billion by the end of 2035, increasing at a CAGR of 6.8% during the forecast period, i.e., 2026-2035. In 2026, the industry size of gangrene treatment is estimated at USD 2.2 billion.

The international market is uplifting, owing to a rise in the patient pool, due to an upsurge in the incidence of peripheral artery disease, diabetes mellitus, and traumatic injuries. According to a report published by the CDC in May 2024, 38.4 million people, or 11.6% of the population in the U.S., are readily affected with diabetes. In addition, 38.1 million adults aged more than 18 years, which is 14.7% of adults in the country, comprised diabetes, thereby leading to an increase in the market’s exposure. Besides, nearly 8.7 million adults within the same age range have successfully met laboratory criteria for the condition, which is also driving the market demand.

Moreover, the supply chain dynamic in the market takes into consideration the gangrene-related therapeutics and devices production that effectively depends on the international APIs chain, surgical tools, hyperbaric systems, and wound dressing. As per the July 2024 AHA Organization data report, the U.S. heavily relies on China for medical supplies and equipment, and the country has readily imported USD 14.9 billion, in comparison to USD 14 billion the previous year. Besides, an estimated 10.5% of global hospitals’ budget, catering to medical supply costs has successfully accounted for USD 146.9 billion as of 2023, denoting an increase of more than USD 6.6 billion as of 2022.